ALL >> General >> View Article
Rznomics: Circular Rna Platform Tech

Rznomics, a biopharmaceutical company, has developed a groundbreaking 'self-circularized RNA structure' platform technology that efficiently generates circular RNA, overcoming the limitations of existing methods.
Circular RNA (circRNA) offers improved stability against nucleases and minimal unwanted immune responses, making it an attractive candidate for vaccines and therapeutics. Rznomics' technology utilizes a unique Tetrahymena trans-splicing ribozyme platform to convert linear RNA into circular RNA through an end-to-end self-targeting and splicing (STS) reaction. Unlike other methods, Rznomics' circularization does not leave unnecessary genetic information in the gene of interest (GOI). The efficiency of the self-circularization process is comparable to other methods, and various optimization strategies can be employed to increase its efficacy, even with long RNA molecules.
The significance of Rznomics' technology lies in its potential for commercialization, enabling more competitive pricing for circRNA vaccines or therapeutics while maintaining efficacy. In vitro transcription initiates the self-circularization ...
... reaction simultaneously, streamlining the purification process. The purified circRNA demonstrates sustained protein expression without unwanted immune responses, outperforming linear RNA with modified nucleotides.
The research was supported by the Ministry of Science & ICT and the National Research Foundation of Korea. Rznomics holds a patent for the 'Self-circularization RNA structure and Platform technology' in South Korea, with applications submitted in the U.S. and other major countries.
Rznomics is a biopharmaceutical company focused on RNA-based gene therapeutic bio-drugs for cancer and incurable diseases. Their core platform technology utilizes an RNA replacement enzyme, trans-splicing ribozyme, to selectively induce therapeutic gene activity in cells expressing target RNA. The company's lead candidate, RZ-001, is intended for treating Hepatocellular Carcinoma & Glioblastoma, with other treatments in the pipeline for Alzheimer's disease and hereditary retinal dystrophy.
More Information : https://www.techdogs.com/tech-news/pr-newswire/rznomics-presents-its-own-circular-rna-platform-technology
Add Comment
General Articles
1. Discover Luxurious Living At Imperial Estates By SapphireAuthor: Star Estate
2. Best Air Conditioning Services In Dubai
Author: Amulya
3. How To Choose Best Software Company Near Me: A Step-by-step Guide
Author: davidjohansen
4. Why Businesses Prefer Working With Software Company Near Me?
Author: davidjohansen
5. 5 Reasons To Hire Software Company Near Me For Your Next Project
Author: davidjohansen
6. Rhode Island Auto Accident Law Firm
Author: Tapalian Law
7. Revolutionize Your Shopping With Try On Clothes Virtually: A Complete Guide
Author: Max
8. How To Choose Reliable Experts For Macbook Repairs?
Author: Fix Laptops
9. British And Irish Lions: Genge Leads As Van Der Merwe Falters
Author: eticketing.co
10. Future Outlook Of The Electric Vehicle market
Author: Rutuja kadam
11. Unforgettable Dubai To Usa Tour Packages – Book Today
Author: nithin
12. What Security Features Should A Jewelry Website Have?
Author: Listany
13. How Lab Automation Is Transforming Healthcare And research
Author: Rutuja kadam
14. Ready To Upgrade? Switch To Udyog Cloud Erp Today!
Author: Udyog
15. Go Digital With Your Loan Services
Author: davidbeckam